Skip to content
Screener

Carlsmed, Inc. CARL Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$16.1MBeat by $1.2M
EPS-$0.32Beat by $0.11
Revenue estimate$14.9M
EPS estimate-$0.43

Next report

Nov 5, 2026 (in 3 months)
Revenue estimate$19.2M
EPS estimate-$0.42

Financials

Q1 2026

Income statement

See full
Revenue$16.1M+58.2%
Gross profit$12.4M+62.7%
Operating income-$9.3M-62.2%
Net income-$8.7M-51.8%
EPS (diluted)-$0.32+78.2%

Balance sheet

See full
Cash & equivalents$73.0M+68.1%
Total debt$17.3M—
Total equity$92.2M+220%
Total assets$118.8M—

Cash flow

See full
Operating cash flow-$13.0M-59.5%
CapEx$79.0K-4.8%
Free cash flow-$13.1M-58.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$241.92M—
Enterprise value$186.16M—
P/S4.3×—

Profitability

See full
Gross margin75.9%+1.4pp
Operating margin-60.5%-10.2pp
Net margin-57.8%-11.2pp
FCF margin-61.1%—

Returns & leverage

See full
Debt / equity0.2×—
Current ratio11.9×—

FAQ

When did Carlsmed, Inc. report Q1 2026 earnings?
Carlsmed, Inc. (CARL) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Carlsmed, Inc.'s Q1 2026 revenue and EPS?
Carlsmed, Inc. reported revenue of $16.1M and eps of $-0.32 for Q1 2026.
Did Carlsmed, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $14.9M by $1.2M. EPS beat the consensus estimate of $-0.43 by $0.11.
Where can I find Carlsmed, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001794546-26-000010) and the 10-Q periodic report (0001794546-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.